Concepedia

Joshua J. Oaks

JJ

Statistics

Publications

14

Citations

2.1K

H-Index

13

Active since

2007

Affiliations

Cancer Genetics (United States)(Current)

The Ohio State University

Medical University of South Carolina

Université de Montréal

MUSC Hollings Cancer Center

Joshua J. Oaks is an author at Cancer Genetics (United States) specializing in medicine, cell biology, and non-coding rna.

Top concepts

Publications per year

2007–2019

14

Publications

14

miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts

Anna M. Eiring, Jason G. Harb, Paolo Neviani et al. · Cell · 2010 · 561 citations · Full text

, , +9

FTY720, a new alternative for treating blast crisis chronic myelogenous leukemia and Philadelphia chromosome–positive acute lymphocytic leukemia

Paolo Neviani, Ramasamy Santhanam, Joshua J. Oaks et al. · Journal of Clinical Investigation · 2007 · 331 citations · Full text

Sphingosine analogue drug FTY720 targets I2PP2A/SET and mediates lung tumour suppression via activation of PP2A‐RIPK1‐dependent necroptosis

Sahar A. Saddoughi, Salih Gencer, Yuri K. Peterson et al. · EMBO Molecular Medicine · 2012 · 262 citations · Full text

PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells

Paolo Neviani, Jason G. Harb, Joshua J. Oaks et al. · Journal of Clinical Investigation · 2013 · 215 citations · Full text

Preclinical and clinical efficacy of XPO1/CRM1 inhibition by the karyopherin inhibitor KPT-330 in Ph+ leukemias

Christopher J. Walker, Joshua J. Oaks, Ramasamy Santhanam et al. · Blood · 2013 · 145 citations · Full text

1–5 of 14